AdjuCor
Munich
About AdjuCor
AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a revolutionary technology for the treatment of advance heart failure patients. Its flagship product is called reBEAT. The market introduction of reBEAT will be the world’s first commercially available, minimal invasive application of mechanical circulatory support for the failing heart that not only provides uni- or biventricular support, but also completely avoids contact with blood. This unique feature set will allow for the transformation of standard-of-care treatment in advanced heart failure setting, as well as greatly expand treatment to previously unreached patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $39.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2023)
- Website: adjucor.com
- Phone: +49 89 262 049 600
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/adjucor-74845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.